PRESAGE BIOSCIENCES

Presage has developed a means of assessing tumor response to drugs or RNA interference agents without the limitations inherent to systemic administration. The Presage clinical surrogate approach enables drug companies to halt development projects for compounds that show no efficacy in the native tumor microenvironment. In addition, the Presage approach can identify drug targets using RNA interference without concern regarding localization or distribution of systemically administered RNAi agents. Presage technology can also be used to identify effective drug combinations in ways that more directly measure the efficacy of such combinations than otherwise possible.

#People #Financial #Website #More

PRESAGE BIOSCIENCES

Social Links:

Industry:

Biotechnology Health Care Medical

Founded:

2008-11-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.presagebio.com

Total Employee:

11+

Status:

Active

Contact:

4087333323

Email Addresses:

[email protected]

Total Funding:

32.57 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving

Current Employees Featured

richard-klinghoffer_image

Richard Klinghoffer
Richard Klinghoffer CEO @ Presage Biosciences
CEO
2018-06-01

james-olson_image

James Olson
James Olson Founder @ Presage Biosciences
Founder
2008-01-01

richard-klinghoffer_image

Richard Klinghoffer
Richard Klinghoffer Chief Scientific Officer @ Presage Biosciences
Chief Scientific Officer

Founder

james-olson_image

James Olson

thane-kreiner_image

Thane Kreiner

Investors List

labcorp-venture-fund_image

Official Site Inspections

http://www.presagebio.com Semrush global rank: 5.56 M Semrush visits lastest month: 1.52 K

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...